Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly cut short when a drug executive fainted as President Donald Trump announced a deal with pharmaceutical companies to reduce prices of obesity medications.
Incident Details
During the event on Thursday, President Trump and representatives from drugmakers Eli Lilly and Novo Nordisk discussed an agreement to expand coverage and lower the costs of popular obesity treatments, Zepbound and Wegovy.
David Ricks, Eli Lilly's CEO, was speaking when he noticed an attendee collapse and asked,
“Are you OK? Gordon, are you OK?”
Response and Identification
The man who fainted was identified as Gordon Findlay, Novo Nordisk’s global brand director. Mehmet Oz, the administrator of the Centers for Medicare & Medicaid Services, quickly assisted as Findlay fell to his knees and collapsed.
The press was then asked to leave the room following the incident. Health and Human Services Secretary was also present during the event.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help a man identified as Gordon Findlay.”
Summary
The unexpected medical emergency interrupted the announcement of efforts to make obesity drugs more affordable for Americans.
Author's summary: A drug executive fainted during President Trump's Oval Office press conference on lowering obesity drug prices, highlighting the urgency of the event.